Post-Transplant Toxicities and Outcomes in Long-Term Survivors of Ex-Vivo CD34+ Selected Allogeneic Hematopoietic Cell Transplantation
Year: 2017
Type: article
Abstract: Introduction: Given limited prior data, we aimed to analyze all high-grade toxicities and associated risk factors after myeloablative conditioned (MAC) allo-HCT with ex-vivoCD34+ selection as GVHD prophylaxis.
Authors: Michael Scordo, Gunjan L. Shah, Satyajit Kosuri, Diego Adrianzen Herrera, Christina Cho, Sean M. Devlin, Molly Maloy, Jimmy Nieves, Taylor Borrill, Dean Carlow, Scott T. Avecilla, Richard Meagher, Richard J. O'Reilly, Guenther Koehne, Boglarka Gyurkocza, Hugo Castro-Malaspina, Roni Tamari, Miguel-Angel Perales, Sergio A. Giralt, Brian Shaffer
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2589159356